Gastroesophageal Reflux Disease is a chronic disorder in which the reflux of stomach contents into the oesophagus causes troublesome symptoms, complications or both. Some degree of gastroesophageal reflux is physiologically normal, particularly after meals, but disease is present when reflux becomes sufficiently frequent or consequential to produce significant symptoms or injury. The term encompasses a spectrum ranging from symptoms without visible mucosal damage to erosive oesophagitis and other complications. Common symptoms include heartburn and regurgitation, while some people experience chest discomfort, swallowing problems, cough or other extra-oesophageal manifestations. The condition results from an imbalance between factors promoting reflux and mechanisms that normally prevent prolonged exposure of the oesophagus to gastric contents.
The lower oesophageal sphincter, the angle between the oesophagus and stomach, diaphragmatic support and normal oesophageal clearance all contribute to limiting reflux. Transient relaxations of the lower oesophageal sphincter can permit stomach contents to move upwards, and impaired clearance can prolong mucosal exposure. Gastric contents may contain acid, digestive enzymes and other substances capable of irritating oesophageal tissue. Reflux becomes more likely or more symptomatic under certain circumstances, including after large meals or when lying down, while individual triggers vary substantially. Anatomical changes such as a hiatus hernia can contribute by altering the relationship between the stomach and diaphragm, although reflux can occur without a hiatus hernia.
Heartburn is classically described as a burning sensation behind the breastbone, while regurgitation refers to the perception of gastric contents moving upwards into the throat or mouth. Some people have symptoms without obvious mucosal injury, whereas others develop erosive oesophagitis that can be demonstrated during endoscopy. More severe or longstanding disease can produce complications such as oesophageal narrowing from scarring, bleeding, or changes in the lining associated with Barrett's oesophagus. Not every person with reflux develops complications, and symptom intensity does not necessarily correspond precisely to the degree of tissue injury. Conversely, significant disease can sometimes occur with relatively modest symptoms, which is why clinical assessment may require objective investigation in selected circumstances.
Diagnosis is often initially based on the symptom pattern, particularly when typical heartburn and regurgitation occur without alarm features. A therapeutic trial of acid-suppressing treatment may sometimes be used as part of clinical assessment, although response to treatment is not perfectly specific for reflux disease. Upper gastrointestinal endoscopy is important when there are alarm symptoms such as progressive difficulty swallowing, unexplained weight loss, gastrointestinal bleeding or other features that warrant direct examination.
Ambulatory reflux monitoring can measure acid exposure and reflux events over time and can be particularly useful when the diagnosis is uncertain or symptoms persist despite treatment. Oesophageal manometry assesses motor function and sphincter physiology and has specialised roles, including evaluation before some anti-reflux procedures and investigation of suspected motility disorders.
Treatment begins with measures tailored to the individual's symptoms and risk factors. Avoiding meals close to bedtime, adjusting meal size and identifying personal dietary triggers can help some people, although broad elimination of large numbers of foods is not universally necessary. Weight reduction can improve reflux in people for whom excess body weight contributes to symptoms, and raising the head of the bed can help some individuals with nocturnal reflux.
Medicines that reduce gastric acid secretion, particularly proton pump inhibitors, are central to treatment for many patients, while other acid-suppressing or symptom-directed medicines may have selected roles. Treatment should be periodically reviewed because long-term medication should be used at an appropriate dose and indication rather than automatically continued at maximum intensity indefinitely.
Persistent reflux can affect sleep, eating behaviour, work performance and quality of life even when serious complications are absent. Repeated exposure of the oesophageal lining to refluxate can cause inflammation and, in some individuals, healing with structural changes. Barrett's oesophagus represents a change in the oesophageal lining associated with chronic reflux and is clinically important because it is associated with an increased risk of oesophageal adenocarcinoma, although the absolute risk for an individual varies and most people with reflux do not develop cancer. Severe erosive disease can recur when treatment is withdrawn, while uncomplicated symptoms may fluctuate over time. These differences illustrate why management should be based on the individual's disease phenotype and objective findings rather than on the assumption that all reflux behaves identically.
Gastroesophageal Reflux Disease has evolved from a predominantly symptom-based concept into a condition assessed through symptoms, mucosal injury and physiological reflux measurements. A major distinction is between gastroesophageal reflux as a normal physiological event and reflux disease as a clinically consequential disorder. Another important distinction is between typical reflux symptoms and symptoms attributed to reflux outside the oesophagus, such as chronic cough or throat symptoms, where causal relationships can be difficult to establish and alternative diagnoses must be considered. A common misconception is that every episode of heartburn proves Gastroesophageal Reflux Disease, while another is that absence of visible erosions rules out clinically significant reflux. Modern assessment recognises both symptomatic disease without erosions and disease with demonstrable tissue injury.
Complications and treatment limitations make appropriate diagnosis important. Acid suppression reduces acidity and can promote healing, but it does not necessarily eliminate the physical movement of gastric contents into the oesophagus, so some symptoms may persist despite good acid control. Refractory symptoms should therefore prompt reconsideration of the diagnosis, adherence, treatment timing and possible alternative mechanisms rather than automatic escalation of medication. Anti-reflux surgery or endoscopic interventions can be considered in selected patients with objectively established reflux, appropriate anatomy and persistent symptoms or complications despite medical treatment. The condition also needs to be distinguished from cardiac and other causes of chest discomfort because burning chest symptoms are not automatically gastrointestinal.
